News

Ionis Selects PANTHERx® Rare as Specialty Distribution Partner

Ionis Selects PANTHERx® Rare as Specialty Distribution Partner

PANTHERx® Rare Selected by Ionis Pharmaceuticals

PANTHERx® Rare, renowned for its pivotal role in providing patient access and support services for rare diseases, has been honored with the selection by Ionis Pharmaceuticals, Inc. This strategic partnership aims to facilitate the distribution of TRYNGOLZA™ (olezarsen), a groundbreaking treatment recognized by the U.S. Food and Drug Administration (FDA) for reducing triglyceride levels in adults suffering from familial chylomicronemia syndrome (FCS).

Understanding TRYNGOLZA™ (olezarsen)

TRYNGOLZA™ is identified as a GalNAc3-conjugated antisense oligonucleotide therapy, designed to selectively target and degrade apoC-III mRNA. This process plays a crucial role in curbing the hepatic production of apoC-III, a protein integral to triglyceride metabolism. FCS, a rare genetic disorder, is marked by extremely elevated plasma triglyceride levels, largely stemming from mutations in the LPL gene. These mutations significantly hinder the functionality of the lipoprotein lipase (LPL) enzyme, which is essential for metabolizing chylomicrons—large particles primarily composed of triglycerides.

The Implications of Familial Chylomicronemia Syndrome (FCS)

In patients with FCS, the impaired ability to break down chylomicrons can lead to a hazardous accumulation of triglycerides in the bloodstream. Such a build-up drastically elevates the risk of acute pancreatitis, a condition that not only entails severe discomfort but can also cause lasting pancreatic damage and, in severe cases, can be life-threatening if not adequately managed. Furthermore, the physical and emotional toll of these symptoms, including hepatosplenomegaly (enlargement of the liver and spleen), chronic fatigue, debilitating abdominal pain, and cognitive impacts such as memory impairment, significantly affects patients' quality of life.

The Partnership's Vision

Rob Snyder, the Executive Chair of PANTHERx® Rare Pharmacy, emphasized the importance of this collaboration with Ionis. He stated, "This partnership will help to redefine life for adults with FCS by streamlining the access and support process. We are excited about the prospect of meeting the needs of patients grappling with this challenging condition by making the pathway to receive their medication more efficient and approachable."

A Commitment to Rare Diseases

PANTHERx Rare, distinguished by dual accreditation, focuses its efforts on supporting individuals grappling with rare and orphan diseases. This specialty pharmacy not only distributes various orphan products but also emphasizes critical access and support services for affected patients. By delivering medicinal breakthroughs along with clinical excellence, PANTHERx strives to transform the lives of those facing devastating health challenges.

The Landscape of Rare Diseases

Currently, the landscape of rare diseases shows a staggering impact, affecting an estimated 25 to 30 million Americans. With over 7,000 rare diseases identified, a significant challenge remains—over 90% lack FDA-approved treatments. However, an increase in federal support and scientific advancements has ushered in a wave of FDA orphan drug approvals, offering a renewed hope to the rare disease community.

Acknowledgments of Excellence

PANTHERx holds twin accreditations, including the Accreditation Commission for Health Care (ACHC) Distinction in Orphan Drugs and the URAC Rare Disease Center of Excellence. Their focus on enhancing patient satisfaction has earned them the prestigious MMIT Patient Choice Award six times, a testament to their dedication and service. PANTHERx is headquartered in Pittsburgh, Pennsylvania, and operates across all 50 states and U.S. territories, aiming to serve patients more effectively.

Frequently Asked Questions

What is TRYNGOLZA™?

TRYNGOLZA™ (olezarsen) is a treatment approved to reduce triglyceride levels in adults with familial chylomicronemia syndrome (FCS).

Who is distributing TRYNGOLZA™?

PANTHERx® Rare has been selected by Ionis Pharmaceuticals for the distribution of TRYNGOLZA™.

What is familial chylomicronemia syndrome?

FCS is a rare genetic disorder characterized by extreme elevations of triglycerides in the blood, often due to mutations affecting the lipoprotein lipase enzyme.

What symptoms are associated with FCS?

Symptoms can include abdominal pain, chronic fatigue, and liver and spleen enlargement, along with potential cognitive impacts.

How does PANTHERx support rare disease patients?

PANTHERx provides access to orphan therapies and offers patient support services, transforming lives with essential healthcare solutions.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

China's APEC Summit: A Catalyst for Business Growth?

Updated Category News Views 48

A Shift Toward Regional Stability China's position as this year's APEC rotating chair presents both opportunity and challenge as economies grapple with trade barriers and technological upheaval. The 33rd APEC Economic Leaders' Meeting in Shenzhen is intended to navigate these turbulent waters, setting the stage for a more stable regional environment. APEC's Role in...

Continue Reading
Sue Egstrand to Lead Karo's Next Growth Phase

Updated Category News Views 117

A New Captain at Karo’s Helm Karo Healthcare is bracing for an exciting ride. Sue Egstrand’s appointment as the new CEO pulls the curtain on what might just be a game-changing era for the company. Set to take the wheel on January 1, 2027, Egstrand brings a heavy-hitting resume—a mash-up of pharmaceutical prowess and a deep-dive into consumer healthcare. Sue’s...

Continue Reading
Gaotu Techedu's Q3 Results: A Look at AI-Driven Growth

Updated Category News Views 56

Gaotu Techedu to Unveil Q3 Results Mark your calendars, folks—Gaotu Techedu Inc. (NYSE: GOTU) is gearing up to dish out its third quarter financial results on November 25, 2026. As usual, these numbers will slide out before the U.S. markets spring into action. It's one of those moments when investors like us strap in and watch for any movement that might toss our...

Continue Reading
Gold Tumbles: Kinross Faces Class Action Lawsuit

Updated Category News Views 79

Digging Deep into Kinross's Legal Fallout Well, here's a doozy for those investing in the precious metal market. Kinross Gold Corporation (NYSE: KGC) finds itself knee-deep in legal muck. Investors who bought into the Canadian gold miner's promises might be scrambling, as a class action lawsuit has just been lobbed their way. The culprit? A hefty drop-off in their...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 382

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
Atomera Preps for Key Craig-Hallum Conference

Updated Category News Views 59

Unpacking the NYC Gathering Alight, let's comb through the moving parts here. Atomera Inc., ticker NASDAQ: ATOM for those eyeing the dance of numbers, is all set to step into the limelight at the 17th Annual Craig-Hallum Alpha Select Conference on November 17, 2026. This shindig isn't just another date on the calendar; it's a strategic haunt where Atomera will rub...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 421

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Envision and Tsinghua Propel Climate Innovation at COP31

Updated Category News Views 87

Collaborating for a Greener Future On the bustling stage of COP31 in Antalya, Turkey, Envision Energy and Tsinghua University teamed up with the Global Alliance of Universities on Climate (GAUC) to showcase a bold agenda. Their focus transcends mere dialogue, pushing for actionable climate solutions anchored in technological innovation, academic synergy, and the dynamism...

Continue Reading
Roche Delivers Endotrophin Assay to Nordic Bioscience Lab

Updated Category News Views 52

Roche Opens New Frontier in Diagnostic Biomarkers Get ready to chew on this: Roche Diagnostics is bringing something new to Nordic Bioscience's CLIA lab. They're offering up their Endotrophin research prototype assay on the cobas® e801 Analyzer. Now, what does this mean for the scientific world? Well, it might just shake things up for those battling cardiovascular and...

Continue Reading
Asia-Pacific Miracle: New Economic Chapter Unfolds

Updated Category News Views 87

A Fresh Breeze in Asia-Pacific's Sails You ever look around and realize everything's about to change—again? That's Asia-Pacific right now. We're staring down the barrel of a new chapter in what folks are calling the "Asia-Pacific miracle." The text from China Daily paints a picture of a region gearing up to crank the cooperation dial even higher. And where's this...

Continue Reading

Top 5 Most Recently Viewed Articles

Choice Hotels Unveils Comprehensive Sustainability Efforts

Updated Category News Views 387

Choice Hotels International Launches 2024 Sustainability Report Choice Hotels International, Inc. (NYSE: CHH), a leading global lodging franchisor, has officially released its 2024 Sustainability Report, showcasing its ongoing commitment to environmental sustainability. The report highlights the company's innovative approaches to reducing its carbon footprint and...

Continue Reading
Revitalizing Communities Through Skilled Trades Initiatives

Updated Category News Views 157

Revitalizing Communities Through Skilled Trades Initiatives In an important moment for many towns across America that are striving for renewal, a new initiative has emerged to shine a light on the necessity of skilled trades. The campaign, titled Careers in Manufacturing, is aimed at highlighting how vital these trades are for both local economies and the workforce on the...

Continue Reading
Color Me Mine Celebrates Growth and Franchise Success

Updated Category News Views 344

Color Me Mine Achieves Remarkable Mid-Year Growth Color Me Mine, a leading paint-your-own pottery franchise, is excited to announce significant growth through its studio expansion and franchisee success. The brand is witnessing a thriving landscape of opportunities, fueled by enthusiastic franchise owners who are making their mark in various communities. Studio Expansion...

Continue Reading
Earnings Insights: Companies Set to Report Soon

Updated Category News Views 202

Upcoming Earnings Reports for Major Companies As the earnings season approaches, investors and analysts eagerly anticipate the financial results from several prominent companies. This article highlights some of the key players expected to announce their quarterly results. Companies Reporting Before the Market Opens UP Fintech Holding (TIGR) UP Fintech Holding is projected...

Continue Reading
Cogent Biosciences Shares Insights at Prestigious Healthcare Event

Updated Category News Views 207

Cogent Biosciences Highlights Participation in Major Healthcare Conference Cogent Biosciences, Inc. (Nasdaq: COGT), a pioneering biotechnology company, is ready to showcase its innovative approach to precision medicine at the highly regarded J.P. Morgan Healthcare Conference. Taking place in San Francisco, this annual event is a crucial platform for industry leaders to...

Continue Reading